Skip to main content
. 2022 May 3;87(1):415–432. doi: 10.3233/JAD-215657

Table 3.

Incidence density of ADRD by a history of CVD, stroke, hypertension, and diabetes in women with breast cancer with up to 26 years of follow-up from 1991 to 2016

Incidence density of ADRD (number of ADRD cases per 1,000 person-years)
Characteristics AD Vascular Lewy FTD MCI Others Total
Cardiovascular disease
  No 18.13 6.98 1.23 0.37 3.80 45.72 48.97
  Yes 30.83 14.12 1.50 0.30 4.16 86.33 92.41
Stroke
  No 18.19 6.78 1.20 0.36 3.58 45.66 48.87
  Yes 29.88 17.18 2.03 0.47 7.41 87.13 93.74
Hypertension
  No 17.07 6.08 1.13 0.33 3.09 39.62 42.46
  Yes 20.20 8.36 1.33 0.39 4.33 54.23 58.06
Diabetes
  No 18.38 6.89 1.21 0.36 3.62 45.09 48.26
  Yes 21.25 9.74 1.43 0.41 4.70 61.84 66.34
Age (years)
  65–69 6.93 2.96 0.65 0.27 2.32 22.35 24.41
  70–74 13.57 5.38 1.13 0.34 3.42 36.05 38.83
  75–79 22.63 8.94 1.56 0.44 4.66 55.12 58.8
  80–84 36.05 13.81 2.11 0.51 5.73 82.90 88.08
  85 or older 52.01 19.55 1.92 0.42 6.17 129.80 137.99
Race/ethnicity
  Whites 18.74 7.2 1.26 0.38 3.90 47.78 51.14
  Blacks 24.20 11.3 1.26 0.30 3.74 60.57 64.94
  Asians/Pacific Islanders 13.35 5.58 0.94 0.26 2.85 38.25 41.87
  Others 20.04 8.15 1.26 0.28 2.66 47.36 50.3
Marital status
  Married 14.09 5.18 1.12 0.32 3.40 36.02 38.81
  Unmarried 23.59 9.64 1.37 0.41 4.22 60.10 64.14
  Unknown 22.06 8.39 1.47 0.46 4.12 55.71 59.62
AJCC tumor stage
  0 and I 17.17 6.63 1.21 0.36 3.97 42.21 45.34
  II 20.50 8.45 1.27 0.38 3.65 51.81 55.32
  III 21.07 7.8 1.35 0.34 3.50 63.60 67.89
  IV 19.96 7.44 0.88 0.19 3.01 91.21 97.39
  Unknown/Missing 30.13 11.43 1.68 0.44 3.52 74.06 79.04
Tumor size (cm)
  < 1 15.90 6.2 1.21 0.36 4.01 39.36 42.46
  1– < 2 18.10 7.03 1.19 0.37 3.85 44.54 47.6
  2– < 3 20.00 8.33 1.30 0.36 3.60 51.11 54.75
  3– < 4 23.19 8.58 1.39 0.34 3.46 61.51 65.35
  ≥4 22.72 9.06 1.31 0.39 3.96 64.04 68.57
  Missing 22.18 8.32 1.35 0.36 3.72 58.72 62.86
Tumor grade
  Well-differentiated 18.10 7 1.35 0.38 4.30 44.94 48.03
  Moderately-differentiated 18.46 7.2 1.23 0.38 3.84 46.64 49.99
  Poorly-differentiated 18.55 7.38 1.20 0.35 3.66 49.95 53.64
  Unknown/Missing 22.79 9.12 1.21 0.31 3.19 56.38 60.14
Hormone receptor status
  Positive 18.18 7.16 1.25 0.38 3.94 46.57 49.93
  Negative 17.98 6.95 1.18 0.34 3.78 48.51 51.99
  Unknown 24.20 9.48 1.33 0.34 3.15 57.95 61.71
Chemotherapy
  No 20.35 8 1.34 0.38 3.96 50.56 54.15
  Yes 12.57 4.88 0.83 0.32 3.20 37.96 40.65
Radiotherapy
  No 24.23 9.53 1.47 0.39 3.91 60.96 65.1
  Yes 14.61 5.72 1.07 0.35 3.74 37.93 40.77
Comorbidity scores
  0 18.53 7.13 1.23 0.36 3.58 45.13 48.3
  1 19.94 8.17 1.32 0.40 4.88 58.64 62.88
  ≥2 25.35 12.72 1.59 0.49 5.36 86.57 93.2
SEER Areas
  Connecticut 21.80 14.04 1.14 0.47 3.76 52.37 56.12
  Detroit 26.06 11.07 1.26 0.35 2.99 57.03 60.33
  Hawaii 17.50 9.71 0.78 0.16 4.04 43.53 47.12
  Iowa 16.72 5.42 1.02 0.31 2.56 45.51 47.7
  New Mexico 16.58 5.74 1.33 0.32 2.91 47.89 50.15
  Seattle 14.07 6.04 0.73 0.25 2.41 35.78 38.91
  Utah 14.26 5.37 0.89 0.18 2.45 41.29 44.01
  Georgia 19.08 6.13 1.33 0.38 3.52 46.49 50.21
  Kentucky 21.57 6.67 1.53 0.43 2.74 57.01 59.26
  Louisiana 19.58 5.93 1.27 0.32 3.26 48.84 52.49
  New Jersey 20.80 8.43 1.43 0.48 4.61 50.60 54.93
  California 17.42 6.18 1.36 0.37 4.92 47.30 50.97
Total 18.92 7.43 1.25 0.37 3.82 48.24 51.66

ADRD, Alzheimer’s disease and related dementias; AD, Alzheimer’s disease; Vascular, vascular dementia; Lewy, dementia with Lewy bodies; FTD, frontotemporal degeneration and dementias; MCI, mild cognitive impairment; Others, other dementias; Total, any of above ADRD.